Rubella Diagnostic Testing Market Expected to Achieve 6.5% CAGR by 2029: Growth Forecast Insights

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

How Large Will the Rubella Diagnostic Testing Market Size By 2025?
There has been robust growth in the rubella diagnostic testing market in the past few years. It's expected to expand from $1.3 billion in 2024 to $1.39 billion in 2025, marking a compound annual growth rate (CAGR) of 6.9%. The historic growth can be credited to escalating vaccination campaigns, an increase in outbreaks that could be prevented with immunization, government efforts to tackle the rubella virus, and the broadening of diagnostic testing outside conventional environments.

How Big Is the Rubella Diagnostic Testing Market Size Expected to Grow by 2029?
Anticipated to see substantial expansion in the coming years is the rubella diagnostic testing market. The sector's growth is projected to reach $1.79 billion in 2029, with a compound annual growth rate (CAGR) of 6.5%. The surge within the predicted period is attributable to the escalating expenditure on healthcare, increased focus on preventive healthcare, higher consciousness about diseases preventable by vaccinations, proliferation of public health initiatives, and the amplification of telemedicine and remote diagnostics. Significant trends in the forecasted time frame encompass progress in diagnostic technologies, incorporation of technology in healthcare systems, creation of point-of-care testing solutions, the evolution of novel diagnostic methods, and advancements in molecular diagnostics.

View the full report here:
https://www.thebusinessresearchcompany.com/report/rubella-diagnostic-testing-global-market-report

Which Key Market Drivers Powering Rubella Diagnostic Testing Market Expansion and Growth?
Anticipated advancement in the rubella diagnostic testing market is expected due to the increase in viral infection cases. Viral infections, diseases caused by microorganisms called viruses that only reproduce within a host's live cells, are on the rise, largely due to the increase in global travel, which allows the viruses to spread cross-border, and climate change, which shifts vector habitats and widens the territory of disease-bearing organisms. Rubella diagnostic tests play a crucial role in the early detection and management of rubella, preventing complications, especially in pregnant women, and helping control outbreaks, thereby minimizing viral proliferation. For example, per the National Health Service - a UK government agency - the daily average for flu-related hospital admissions in December 2023 was 234, a 53% weekly increase; while daily hospital cases due to norovirus went up by 15% to an average of 406 daily, a leap of 28% compared to the same week the previous year. This escalation in viral infection cases underpins the projected growth of the rubella diagnostic testing market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=19177&type=smp

Which Fast-Growing Trends Are Poised to Disrupt the Rubella Diagnostic Testing Market?
Key players in the rubella diagnostic testing market are concentrating their efforts on creating novel solutions, such as a vaccine for the rubella virus. This focus aims to better diagnostic precision and heighten preventative steps. The said vaccine offers rubella immunity and is typically given as a constituent of MMR or MMRV combination vaccines to ward off the illness and its related complications. For example, in March 2023, Merck & Co., Inc., a pharmaceutical firm headquartered in the US, received the FDA's green light for the intramuscular (IM) delivery of its M-M-R II vaccine. Notably, this vaccine is a significant defense against rubella, mumps, and measles. This approval authorizes healthcare providers to give the rubella vaccine via the IM method, aligning it with other usually recommended childhood vaccines. Vaccination against rubella is crucial for outbreak prevention and safeguarding against the virus's serious complications, especially in expectant mothers.

What Are the Emerging Segments in the Rubella Diagnostic Testing Market?
The rubella diagnostic testingmarket covered in this report is segmented -

1) By Diagnostic Technique: Latex Agglutination, Liver Function Tests, Enzyme Immunoassay (EIA), Radioimmunoassay (Ria), Fluorescent Immunoassay (FIA), Other Diagnostic Techniques
2) By Age Group: Neonates, Teenagers, Adults
3) By End User: Hospitals And Clinics, Cancer Diagnostic Centers, Ambulatory Surgical Centers, Other End Users

Subsegments:
1) By Latex Agglutination: Qualitative Latex Agglutination Tests, Quantitative Latex Agglutination Tests, Rapid Latex Agglutination Kits
2) By Liver Function Tests: Serum Bilirubin Tests, Alanine Aminotransferase (ALT) Tests, Aspartate Aminotransferase (AST) Tests, Alkaline Phosphatase (ALP) Tests, Other Liver Enzyme Tests
3) By Enzyme Immunoassay (EIA): Direct EIA, Indirect EIA, Sandwich EIA, Competitive EIA
4) By Radioimmunoassay (RIA): Standard RIA, Modified RIA, Single-Antibody RIA
5) By Fluorescent Immunoassay (FIA): Direct FIA, Indirect FIA, Sandwich FIA
6) Other Diagnostic Techniques: Polymerase Chain Reaction (PCR), Nucleic Acid Amplification Tests (NAAT), Microplate-Based Assays, Western Blotting

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=19177&type=smp

Who Are the Global Leaders in the Rubella Diagnostic Testing Market?
Major companies operating in the rubella diagnostic testing market are Cardinal Health Inc., Siemens Healthineers AG, Thermo Fisher Scientific Inc., Abbott Laboratories, F. Hoffmann-La Roche Ltd., bioMérieux S.A., Bio-Rad Laboratories Inc., Ortho-Clinical Diagnostics Inc., DiaSorin S.p.A., Meridian Bioscience Inc., Fortress Diagnostics Ltd., Mylab Discovery Solutions Pvt. Ltd., MP Biomedicals LLC, CTK Biotech Inc., ZEUS Scientific Inc., Creative Diagnostics, Arlington Scientific Inc., AccuBioTech Co. Ltd., Intec Products Inc., Vitrosens Biotechnology Ltd., Sprint Diagnostics Pvt. Ltd., InDevR Inc., Atlas Medical GmbH

Which are the Top Profitable Regional Markets for the Rubella Diagnostic Testing Industry?
North America was the largest region in the rubella diagnostic testing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the rubella diagnostic testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=19177

This Report Supports:
1. Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2. Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3. Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4. Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Learn More About The Business Research Company
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Europe +44 7882 955267
Asia & Others +44 7882 955267 & +91 8897263534
Email us at info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 7882 955267,
Asia: +91 88972 63534,
Americas: +1 310-496-7795 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.